NCT04800133View on ClinicalTrials.gov

Covid-19 Vaccination in Adolescents and Children

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

1,018

Participants

Timeline

Start Date

May 8, 2021

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Covid19
Interventions
BIOLOGICAL

Tozinameran

mRNA vaccine developed by BioNTech against COVID-19

BIOLOGICAL

CoronaVac

Inactivated virus vaccine developed by SinoVac against COVID-19, intramuscular

BIOLOGICAL

CoronaVac, intradermal

Inactivated virus vaccine developed by SinoVac against COVID-19, intradermal

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER